carmustine has been researched along with Meningioma in 7 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Meningioma: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-three patients with brain tumors were entered into the study." | 1.29 | Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy. ( Kowada, M; Mineura, K; Watanabe, K; Yanagisawa, T; Yasui, N, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schnurman, Z | 1 |
| Kondziolka, D | 1 |
| Nemoto, S | 1 |
| Mineura, K | 1 |
| Yanagisawa, T | 1 |
| Watanabe, K | 1 |
| Kowada, M | 1 |
| Yasui, N | 1 |
| Kornblith, PL | 1 |
| Szypko, PE | 1 |
| Salcman, M | 1 |
| Constine, LS | 1 |
| Rubin, P | 1 |
| Woolf, PD | 1 |
| Doane, K | 1 |
| Lush, CM | 1 |
| Panasci, LC | 1 |
| Dufour, M | 1 |
| Chevalier, L | 1 |
| Isabel, G | 1 |
| Lazarus, P | 1 |
| McQuillan, A | 1 |
| Arbit, E | 1 |
| Brem, S | 1 |
| Feindel, W | 1 |
1 review available for carmustine and Meningioma
| Article | Year |
|---|---|
The morbidity and mortality of brain tumors. A perspective on recent advances in therapy.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms | 1985 |
6 other studies available for carmustine and Meningioma
| Article | Year |
|---|---|
Evaluating innovation. Part 2: Development in neurosurgery.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Carmustine; Deep Brain Stimulation; Depression; | 2016 |
[Intravascular surgery for brain tumors].
Topics: Brain Neoplasms; Carmustine; Chemoembolization, Therapeutic; Humans; Meningeal Neoplasms; Meningioma | 1993 |
Human brain tumor O(6)-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy.
Topics: Antineoplastic Agents, Alkylating; Biomarkers; Brain Neoplasms; Carmustine; DNA Repair; Glioma; Huma | 1996 |
Variations in response of human brain tumors to BCNU in vitro.
Topics: Brain Neoplasms; Carmustine; Cells, Cultured; Glioma; Humans; Meningeal Neoplasms; Meningioma | 1978 |
Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; Child; Child, Preschool; | 1987 |
Utilization of the HTSCA and CFU-C assay to identify two new 2-chloroethylnitrosourea congeners of amino acid amides with increased in vitro activity against human glioma compared with BCNU.
Topics: Antineoplastic Agents; Bone Marrow; Carmustine; Colony-Forming Units Assay; Glioma; Humans; In Vitro | 1985 |